IMPACT BIOMEDICAL INC. - 10-Q Filing
Impact BioMedical reported a net loss of $2.28 million for the three months ended March 31, 2026, compared to a net loss of $1.28 million in the same period last year. The company generated $7,000 in biotech retail sales during Q1 2026 but faced rising costs and expenses totaling $2.29 million.
Tickers: $IBO